Nicholas Maestas
CIK: 0001871423
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 17, 2026RANI
Rani Therapeutics Holdings, Inc.
Award(A)DirectStock Option (Right to Buy)
2M shares- - Mar 31, 2026TPST
Tempest Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
140K shares- - Jan 2, 2025TPST
Tempest Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 17, 2026 |  RANI Rani Therapeutics Holdings, Inc. | Award(A) Stock Option (Right to Buy) | 2,000,000 | - | - | Direct |
| Mar 31, 2026 |  TPST Tempest Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 140,000 | - | - | Direct |
| Jan 2, 2025 | TPST Tempest Therapeutics, Inc. | Award(A) Employee Stock Option (right to buy) | 200,000 | - | - | Direct |
1-3 of 3 transactions
About Maestas Nicholas
Maestas Nicholas (SEC CIK 0001871423) files insider reports with the SEC as Chief Financial Officer of Rani Therapeutics Holdings, Inc. (RANI) and Chief Financial Officer of Tempest Therapeutics, Inc. (TPST).
Signal8 holds 4 ownership filings by Maestas Nicholas (1 Form 3, 3 Form 4), filed between Jan 6, 2025 and Jul 21, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Jul 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Maestas Nicholas's filings is in SAN JOSE, CA.
Recent filings by Maestas Nicholas
Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)
- Imran Talat, Chief Executive Officer
- Javadi Alireza, Chief Technical Officer
- Gilson Michelle, Director
- IMRAN MIR A, Director
- McKinley Kate, Chief Business Officer
- Bassan Abraham, Director